NDP
Basic information
Region (hg38): X:43948776-43973395
Previous symbols: [ "EVR2" ]
Links
Phenotypes
GenCC
Source:
- Norrie disease (Definitive), mode of inheritance: XL
- Norrie disease (Supportive), mode of inheritance: XL
- exudative vitreoretinopathy (Supportive), mode of inheritance: AD
- persistent hyperplastic primary vitreous (Supportive), mode of inheritance: AD
- Norrie disease (Strong), mode of inheritance: XL
- exudative vitreoretinopathy 2, X-linked (Strong), mode of inheritance: XL
- Norrie disease (Definitive), mode of inheritance: XL
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Norrie disease; Exudative vitreoretinopathy, 2, X-linked | XL | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Ophthalmologic | 95062; 1303235; 1307245; 1642288; 8252044; 8457509; 8110678; 7662640; 7814011; 7795608; 7627181; 8990009; 17325173; 17334993; 20301506; 20491809; 20679667; 21179243; 21960066; 22563645; 22674248 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (21 variants)
- Retinal dystrophy (10 variants)
- Atrophia bulborum hereditaria (7 variants)
- Exudative vitreoretinopathy 2, X-linked (2 variants)
- Exudative vitreoretinopathy, X-linked (1 variants)
- Atrophia bulborum hereditaria;Exudative vitreoretinopathy 2, X-linked (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the NDP gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 19 | 22 | ||||
missense | 11 | 16 | 39 | 68 | ||
nonsense | 10 | 14 | ||||
start loss | 1 | |||||
frameshift | 15 | |||||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 3 | |||||
splice region | 2 | 2 | 4 | |||
non coding | 16 | |||||
Total | 32 | 28 | 43 | 27 | 10 |
Variants in NDP
This is a list of pathogenic ClinVar variants found in the NDP region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
X-43949084-A-G | not specified | Likely benign (-) | ||
X-43949605-G-GGAAAA | Uncertain significance (Aug 28, 2019) | |||
X-43949785-C-T | History of neurodevelopmental disorder | Conflicting classifications of pathogenicity (Dec 23, 2018) | ||
X-43949789-G-C | not specified | Benign (Apr 25, 2019) | ||
X-43949796-G-T | NDP-related disorder | Uncertain significance (Mar 05, 2019) | ||
X-43949808-G-T | Likely pathogenic (Jul 18, 2019) | |||
X-43949812-T-C | Uncertain significance (Oct 05, 2023) | |||
X-43949813-C-A | Likely pathogenic (Aug 19, 2022) | |||
X-43949814-C-T | Benign (Jan 06, 2024) | |||
X-43949816-C-T | Conflicting classifications of pathogenicity (Aug 23, 2023) | |||
X-43949817-G-A | Likely benign (Oct 02, 2023) | |||
X-43949817-G-C | Retinal dystrophy | Pathogenic (May 27, 2024) | ||
X-43949817-G-T | Atrophia bulborum hereditaria | Pathogenic (Jul 28, 2023) | ||
X-43949823-A-T | Retinal dystrophy | Pathogenic (Jan 01, 2007) | ||
X-43949831-G-A | Exudative vitreoretinopathy 2, X-linked | Pathogenic (Apr 27, 2023) | ||
X-43949833-A-T | Likely pathogenic (Oct 22, 2023) | |||
X-43949836-T-C | Uncertain significance (Feb 23, 2015) | |||
X-43949838-C-A | Likely benign (Jan 28, 2022) | |||
X-43949839-C-A | Exudative vitreoretinopathy 2, X-linked | Pathogenic (Sep 01, 1996) | ||
X-43949839-C-T | Retinal dystrophy | Pathogenic (Jan 01, 2022) | ||
X-43949840-G-A | Exudative vitreoretinopathy 2, X-linked • Atrophia bulborum hereditaria • Retinal dystrophy | Pathogenic/Likely pathogenic (Jul 12, 2023) | ||
X-43949846-T-G | Atrophia bulborum hereditaria | Likely pathogenic (May 25, 2021) | ||
X-43949851-G-GTGAGTCGCATGCCCCC | Exudative vitreoretinopathy 2, X-linked;Atrophia bulborum hereditaria | Likely pathogenic (-) | ||
X-43949855-G-A | Uncertain significance (Nov 13, 2022) | |||
X-43949858-G-A | Pathogenic (Dec 30, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
NDP | protein_coding | protein_coding | ENST00000378062 | 2 | 24729 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.650 | 0.326 | 0 | 0 | 0 | 0 | 0.00 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.969 | 31 | 50.4 | 0.616 | 0.00000330 | 855 |
Missense in Polyphen | 5 | 22.881 | 0.21853 | 392 | ||
Synonymous | -0.757 | 26 | 21.5 | 1.21 | 0.00000144 | 272 |
Loss of Function | 1.71 | 0 | 3.39 | 0.00 | 2.12e-7 | 55 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00 | 0.00 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Activates the canonical Wnt signaling pathway through FZD4 and LRP5 coreceptor. Plays a central role in retinal vascularization by acting as a ligand for FZD4 that signals via stabilizing beta-catenin (CTNNB1) and activating LEF/TCF-mediated transcriptional programs. Acts in concert with TSPAN12 to activate FZD4 independently of the Wnt-dependent activation of FZD4, suggesting the existence of a Wnt-independent signaling that also promote accumulation the beta-catenin (CTNNB1). May be involved in a pathway that regulates neural cell differentiation and proliferation. Possible role in neuroectodermal cell-cell interaction.;
- Disease
- DISEASE: Vitreoretinopathy, exudative 2 (EVR2) [MIM:305390]: A disorder of the retinal vasculature characterized by an abrupt cessation of growth of peripheral capillaries, leading to an avascular peripheral retina. This may lead to compensatory retinal neovascularization, which is thought to be induced by hypoxia from the initial avascular insult. New vessels are prone to leakage and rupture causing exudates and bleeding, followed by scarring, retinal detachment and blindness. Clinical features can be highly variable, even within the same family. Patients with mild forms of the disease are asymptomatic, and their only disease related abnormality is an arc of avascular retina in the extreme temporal periphery. {ECO:0000269|PubMed:16163268, ECO:0000269|PubMed:16970763, ECO:0000269|PubMed:17296899, ECO:0000269|PubMed:17325173, ECO:0000269|PubMed:8252044, ECO:0000269|PubMed:8946107, ECO:0000269|PubMed:9143917}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- GPCR signaling-G alpha q;GPCR signaling-cholera toxin;GPCR signaling-pertussis toxin;GPCR signaling-G alpha s Epac and ERK;GPCR signaling-G alpha s PKA and ERK;GPCR signaling-G alpha i
(Consensus)
Recessive Scores
- pRec
- 0.479
Intolerance Scores
- loftool
- rvis_EVS
- 0.28
- rvis_percentile_EVS
- 70.87
Haploinsufficiency Scores
- pHI
- 0.414
- hipred
- Y
- hipred_score
- 0.722
- ghis
- 0.526
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.234
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ndp
- Phenotype
- cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); pigmentation phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hearing/vestibular/ear phenotype; vision/eye phenotype; skeleton phenotype;
Zebrafish Information Network
- Gene name
- ndp
- Affected structure
- ocular blood vessel
- Phenotype tag
- abnormal
- Phenotype quality
- decreased area
Gene ontology
- Biological process
- placenta development;vacuole organization;signal transduction;cell-cell signaling;nervous system development;visual perception;sensory perception of sound;cell population proliferation;regulation of signaling receptor activity;Wnt signaling pathway;extracellular matrix-cell signaling;positive regulation of transcription, DNA-templated;positive regulation of DNA-binding transcription factor activity;canonical Wnt signaling pathway;retina vasculature morphogenesis in camera-type eye
- Cellular component
- extracellular space;cell surface;collagen-containing extracellular matrix
- Molecular function
- frizzled binding;cytokine activity;protein binding;growth factor activity;protein homodimerization activity